- Home
- LSPD vs IOVA Comparison
LSPD vs IOVA Comparison
Compare LSPD & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- IOVA
- Stock Information
- Founded
- LSPD 2005
- IOVA 2007
- Country
- LSPD Canada
- IOVA United States
- Employees
- LSPD N/A
- IOVA N/A
- Industry
- LSPD
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSPD
- IOVA Health Care
- Exchange
- LSPD Nasdaq
- IOVA Nasdaq
- Market Cap
- LSPD 2.7B
- IOVA 3.0B
- IPO Year
- LSPD 2020
- IOVA N/A
- Fundamental
- Price
- LSPD $17.28
- IOVA $8.18
- Analyst Decision
- LSPD Buy
- IOVA Strong Buy
- Analyst Count
- LSPD 14
- IOVA 9
- Target Price
- LSPD $18.68
- IOVA $23.33
- AVG Volume (30 Days)
- LSPD 1.0M
- IOVA 7.8M
- Earning Date
- LSPD 11-07-2024
- IOVA 11-07-2024
- Dividend Yield
- LSPD N/A
- IOVA N/A
- EPS Growth
- LSPD N/A
- IOVA N/A
- EPS
- LSPD N/A
- IOVA N/A
- Revenue
- LSPD $1,013,184,000.00
- IOVA $90,858,000.00
- Revenue This Year
- LSPD $23.40
- IOVA $13,827.67
- Revenue Next Year
- LSPD $18.81
- IOVA $183.70
- P/E Ratio
- LSPD N/A
- IOVA N/A
- Revenue Growth
- LSPD 24.73
- IOVA 12751.20
- 52 Week Low
- LSPD $11.01
- IOVA $4.44
- 52 Week High
- LSPD $21.71
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- LSPD 62.66
- IOVA 32.59
- Support Level
- LSPD $16.62
- IOVA $9.31
- Resistance Level
- LSPD $18.88
- IOVA $10.86
- Average True Range (ATR)
- LSPD 0.60
- IOVA 0.71
- MACD
- LSPD 0.20
- IOVA -0.37
- Stochastic Oscillator
- LSPD 61.14
- IOVA 1.48
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.